GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » InnoCan Pharma Corp (XCNQ:INNO) » Definitions » Float Percentage Of Total Shares Outstanding

InnoCan Pharma (XCNQ:INNO) Float Percentage Of Total Shares Outstanding : 0.00% (As of Apr. 13, 2025)


View and export this data going back to 2019. Start your Free Trial

What is InnoCan Pharma Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, InnoCan Pharma's float shares is 0.00 Mil. InnoCan Pharma's total shares outstanding is 291.23 Mil. InnoCan Pharma's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, InnoCan Pharma's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, InnoCan Pharma's Institutional Ownership is 0.18%.

InnoCan Pharma Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

InnoCan Pharma's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/291.23
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InnoCan Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » InnoCan Pharma Corp (XCNQ:INNO) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
TSXV:ZYUS XCNQ:BNXT XCNQ:FNT.U TSXV:HASH TSX:MDP XCNQ:VEXT XCNQ:JUSH TSX:LABS TSXV:LSL TSXV:DB ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
INNPF:USA IP4:Germany
Address
1015, 926 - 5 Avenue SW, Calgary, AB, CAN, T2P 0N7
Website
https://www.innocanpharma.com
InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue from the United States.
Executives
Peter David Bloch Director
William Colin Macdonald Director

InnoCan Pharma Headlines